Intra Cellular Therapies shares owned by Citadel Advisors
Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Intra Cellular Therapies
Tip: Access up to 7 years of quarterly data
All positions including Intra Cellular Therapies held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Intra Cellular Therapies by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $301M | 2.3M | 131.92 |
| 2024-12-31 | $13M | 158k | 83.52 |
| 2024-09-30 | $4.6M | 62k | 73.17 |
| 2024-06-30 | $15M | 217k | 68.49 |
| 2024-03-31 | $37M | 540k | 69.20 |
| 2023-12-31 | $8.0M | 111k | 71.62 |
| 2023-09-30 | $7.2M | 138k | 52.09 |
| 2023-06-30 | $3.5M | 55k | 63.32 |
| 2023-03-31 | $38M | 692k | 54.15 |
| 2022-12-31 | $40M | 751k | 52.92 |
| 2022-06-30 | $31M | 542k | 57.08 |
| 2022-03-31 | $44M | 713k | 61.19 |
| 2021-12-31 | $52M | 1.0M | 52.34 |
| 2021-09-30 | $49M | 1.3M | 37.28 |
| 2021-06-30 | $69M | 1.7M | 40.82 |
| 2021-03-31 | $55M | 1.6M | 33.93 |
| 2020-12-31 | $53M | 1.7M | 31.80 |
| 2020-09-30 | $37M | 1.5M | 25.66 |
| 2020-06-30 | $23M | 877k | 25.67 |
| 2020-03-31 | $7.0M | 456k | 15.40 |
| 2019-12-31 | $94M | 2.7M | 34.31 |
| 2019-09-30 | $12M | 1.5M | 7.47 |
| 2019-06-30 | $7.4M | 568k | 12.98 |
| 2019-03-31 | $2.7M | 220k | 12.15 |
| 2018-12-31 | $14M | 1.3M | 11.39 |
| 2018-09-30 | $19M | 875k | 21.72 |
| 2018-06-30 | $25M | 1.4M | 17.67 |
| 2018-03-31 | $25M | 1.2M | 21.02 |
| 2017-12-31 | $3.1M | 211k | 14.47 |
| 2017-09-30 | $1.7M | 106k | 15.78 |
| 2017-06-30 | $18M | 1.4M | 12.43 |
| 2017-03-31 | $13M | 824k | 16.25 |
| 2016-12-31 | $19M | 1.3M | 15.09 |
| 2016-09-30 | $1.8M | 116k | 15.24 |
| 2016-06-30 | $887k | 23k | 38.80 |
| 2016-03-31 | $272k | 9.8k | 27.78 |
| 2015-12-31 | $428k | 8.0k | 53.79 |
| 2015-09-30 | $2.2M | 54k | 40.05 |
| 2015-03-31 | $3.0M | 126k | 23.88 |
Top funds holding Intra Cellular Therapies
View all funds holding Intra Cellular Therapies